103626-04-6 Usage
Description
Ethyl 3-methoxy-1-methyl-1H-pyrazole-4-carboxylate is an organic compound that serves as a key intermediate in the synthesis of various chemical compounds. It is characterized by its pyrazole ring structure, which is a five-membered heterocyclic ring containing nitrogen atoms, and an ester functional group. ethyl 3-methoxy-1-methyl-1H-pyrazole-4-carboxylate is known for its potential applications in the development of herbicidal agents and other chemical products.
Uses
Used in Herbicide Industry:
Ethyl 3-methoxy-1-methyl-1H-pyrazole-4-carboxylate is used as a reagent for the preparation of pyrazole-4-carboxamide derivatives with herbicidal activity. These derivatives are effective in controlling the growth of various weeds, making them valuable for agricultural and horticultural applications. ethyl 3-methoxy-1-methyl-1H-pyrazole-4-carboxylate's ability to form herbicidal agents contributes to its significance in the development of new and improved weed control products.
Check Digit Verification of cas no
The CAS Registry Mumber 103626-04-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,6,2 and 6 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 103626-04:
(8*1)+(7*0)+(6*3)+(5*6)+(4*2)+(3*6)+(2*0)+(1*4)=86
86 % 10 = 6
So 103626-04-6 is a valid CAS Registry Number.
103626-04-6Relevant articles and documents
USE OF MORPHINAN DERIVATIVES FOR TREATMENT OF OPIOID RECEPTOR AGONIST-RELATED DISEASES
-
, (2019/08/01)
The present invention relates to a pharmaceutical composition comprising a morphinan derivative that exhibits an opioid δ receptor agonist activity. By administering the pharmaceutical composition provided by the present invention, opioid δ receptor-related diseases (for example, headache) can be treated or prevented.
1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms
-
, (2008/06/13)
This invention relates to novel 1,3-dimethylbutylcarboxanilides of the formula (I) in which A, R1 and R2 are as defined in the disclosure, to a plurality of processes for preparing these compounds and their use for controlling unwant
Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids.
Cottineau, Bertrand,Toto, Patrick,Marot, Christophe,Pipaud, Aline,Chenault, Jacques
, p. 2105 - 2108 (2007/10/03)
The synthesis and in vivo activities of a series of substituted pyrazole-4-carboxylic acids as hypoglycemic agents are described. Modelization of some potent compounds, comparatively to the metformine, presents certain analogies permitting to predict the design of some novel antidiabetic drugs.
